Project (KOMP) which aims to create GEMs where ultimately every known protein coding gene in the mouse is inactivated 3 . Other large-scale projects include aging studies 4, 5 , mutagenesis strategies 6, 7 , and new approaches to generate genetically diverse outbred stocks (diversity outcross) 8 and inbred strains (collaborative cross) 9 . Accurate evaluation and interpretation of these mice requires clinical evaluation, gross necropsy, and histopathological phenotyping 10 . Comparison of the diseases these mice develop to human disease, to find the best fit, the so-called "Cinderella effect" 11 , involves collaboration between veterinarians, who understand the mouse disease and lesions, and physicians, who deal with the human patients. While the technologies to create mutant mice have become more or less routine, there remains a critical shortage of expert pathologists to do the requisite pathology-based phenotyping in which accurate interpretation of lesions are made combined with comparisons with human diseases 12 .
Veterinary pathologists are trained in the gross and histopathology of multiple species but have limited knowledge of human pathology, and their experience with laboratory mice is generally restricted to the diagnosis of infectious disease in standard domestic and research animals. Many veterinary pathologists gain expertise in toxicologic pathology while evaluating rodent tissues for the pharmaceutical and chemical industries, but, in general, they are not trained in the nuances of mouse genetics or the types of lesions to be expected in GEMs. By contrast, physicians have extensive knowledge of human disease but are not well versed in the intricacies of mouse anatomy, pathology, and genetics or the concept of comparative pathology. Both groups, physicians and veterinarians, have the basic skills to generate high quality evaluation of mouse models, but all need the confidence they can do this.
To address this issue, the first large meeting, Pathology of Genetically Engineered Mice, was held in 1999 at the NIH in Bethesda, Maryland. This meeting resulted in the production of a well-regarded textbook 13 , and additional books ( Table 1 ) and reviews have subsequently provided traditional resources. Many pathologists working with mice do so in small groups or in isolation at their institutions. The small workshop format of the Pathology of Mouse Models of Human Disease Workshops, consisting of 20-25 participants and 15 or more faculty (Fig. 1) , is designed to encourage interaction among all participants, and has resulted in the development of many collaborations and, perhaps more importantly, confidence for the attendees to seek consultation with the faculty. Variations in this format are now commonly used in similar meetings around the world, often involving the organizers of this series.
The workshop format has evolved to include open evening discussions on cases or research projects using whole slide scanned images. Presentations cover mouse genetics and genetic nomenclature, didactic sessions covering specific diseases and organ systems, embryonic lethal analyses, stem cell and regenerative medicine, technologies for creating GEMs, and the most current Conference Center at The Jackson Laboratory in Bar Harbor, ME. The objective of this workshop was to cover phenotyping mouse models of human disease from the pathologist's perspective and to provide veterinary and human pathologists and pathology residents an overview of the latest technologies ranging from creating mouse models with genetic engineering technologies to evaluating them at the molecular, physiological, and histopathological levels. The meeting discussed the use of mice for modelling human disease for understanding the causes and pathogenesis (mechanisms) of disease, developing therapies, and methods of prevention. Discussions included all disease classifications -genetic, infectious, immune mediated, degenerative, aging, cardiovascular, cancer, and many others, focusing on specific models developed by the faculty.
The laboratory mouse has been critical to biomedical research since Clarence Cook Little defied the thoughts of the day nearly a century ago by creating the first inbred mouse strain 1 .
Over the last 50 years the laboratory mouse has become the standard biomedical research model organism to study for a wide variety of human diseases. While fish, worms, flies, and other non-mammalian species also serve this purpose, most lack critical anatomical structures or physiological processes found in humans and mice, which limits many types of investigations, especially translational studies. Over 60% of the National Institutes of Health (NIH)-funded research involves rodents, with mice representing 80-90% of the animals used 2 . Detailed characterization of the mouse genome and extensive sets of tools available for genetic modifications also assure continuous use of the mouse as the leading model organism.
Spontaneous (naturally occurring) mutations in mice were, for many years, the unique, albeit relatively rare, source of new mouse biomedical models. The advent of genetically engineered mice (GEMs), which includes transgenesis (moving genes from one species to another or overexpressing a gene), targeted mutagenesis (so-called knockout mice), inducible models with or without molecular markers, and more recent endonuclease modified models, continue to make the laboratory mouse a very utilitarian biological tool. Breakthroughs using mouse models have provided crucial insight into the pathogenesis of numerous diseases affecting all organ systems. These technologies evolved from small scale projects within principal investigator's research laboratories, to large-scale international projects such as the Knockout Mouse 17, 18 .
These annual workshops provide a state-of-the-art overview of the pathology of GEMs and other mouse models of human disease as well as spontaneous diseases affecting aging inbred strains and results of experimental manipulations. More importantly, 
